3230-94-2 | L-Ornithine l-aspartate salt

Packsize	Purity	Availability	Price	Discounted Price
1g	95%	in stock	$15.00	$10.00
10g	95%	in stock	$16.00	$11.00
25g	95%	in stock	$20.00	$14.00
100g	95%	in stock	$39.00	$27.00
500g	95%	in stock	$139.00	$97.00
1000g	95%	in stock	$240.00	$168.00

Description

• Catalog Number: AD48178
• Chemical Name: L-Ornithine l-aspartate salt
• CAS Number: 3230-94-2
• Molecular Formula: C9H19N3O6
• Molecular Weight: 265.26366
• MDL Number: MFCD00058084
• SMILES: N[C@H](C(=O)O)CCCN.OC(=O)C[C@@H](C(=O)O)N

Computed Properties

• Complexity: 228
• Covalently-Bonded Unit Count: 2
• Defined Atom Stereocenter Count: 2
• Heavy Atom Count: 18
• Hydrogen Bond Acceptor Count: 9
• Hydrogen Bond Donor Count: 6
• Rotatable Bond Count: 7

Literature

• [Hepatic encephalopathy and liver transplantation].

  Magyar sebeszet 20120401

• Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20111101

• A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.

  European journal of gastroenterology & hepatology 20110801

• Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.

  Annals of hepatology 20110601

• Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure.

  Annals of hepatology 20110601

• Interorgan ammonia metabolism in liver failure: the basis of current and future therapies.

  Liver international : official journal of the International Association for the Study of the Liver 20110201

• Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study.

  Clinical drug investigation 20110101

• [Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110101

• The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.

  Acta medica Indonesiana 20110101

• [Optimization of treatment of patients with chronic cardiac insufficiency of the ischemic genesis and hobnail liver].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101

• Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.

  Acta medica Indonesiana 20100701

• [Hepatic encephalopathy. L-ornithine-L-aspartate stimulate detoxification capacity of the liver].

  MMW Fortschritte der Medizin 20100603

• A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.

  Liver international : official journal of the International Association for the Study of the Liver 20100401

• Treatment of hyperammonemia in liver failure: a tale of two enzymes.

  Gastroenterology 20090601

• Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study.

  Gastroenterology 20090601

• L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis.

  Journal of gastroenterology and hepatology 20090101

• A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment.

  Arquivos de gastroenterologia 20090101

• L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20081101

• The treatment of hepatic encephalopathy.

  Metabolic brain disease 20071201

• [Fulminate liver failure in a 39-year-old female patient with leukocytosis, unclear fever, and arthralgic pain].

  Medizinische Klinik (Munich, Germany : 1983) 20071015

• Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction.

  Metabolic brain disease 20070301

• [New approach to diagnostics and correction of portohepatic hemodynamics in patients with chronic liver diseases].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101

• Pharmacokinetics and bioavailability study of L-ornithine-L-aspartate in healthy volunteers--a comparative study of two oral formulations.

  Journal of pharmaceutical and biomedical analysis 20060607

• Validated method for L-ornithine-L-aspartate analysis in human plasma by capillary electrophoresis.

  Biomedical chromatography : BMC 20060201

• Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.

  Annals of hepatology 20060101

• [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20050601

• [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].

  Zeitschrift fur Gastroenterologie 20050401

• Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy.

  Metabolic brain disease 20050301

• Effect of ascorbic acid, alpha-tocopherol, lecithin and L-ornithine-L-aspartate on ethanol induced hypoproteinemia and hyperlipidemia in rats.

  Indian journal of physiology and pharmacology 20050101

• [New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects].

  Gastroenterologia y hepatologia 20040201

• [Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain].

  MMW Fortschritte der Medizin 20040129

• [Hepatic encephalopathy--therapy].

  Deutsche medizinische Wochenschrift (1946) 20031212

• Brain edema in acute liver failure.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20031201

• [Because hepatic encephalopathy is a frequent contributing factor. Patients with liver cirrhosis are poorer drivers].

  MMW Fortschritte der Medizin 20031120

• Hepatic encephalopathy: nomenclature, pathogenesis and treatment.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20030201

• Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy.

  Metabolic brain disease 20021201

• [Researching progress of prevention and treatment of hepatic failure encephalopathy].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20020801

• Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment--results of a pilot study.

  Metabolic brain disease 20020601

• [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].

  Klinicheskaia meditsina 20020101

• [Chronic liver diseases. The nihilism has gone].

  MMW Fortschritte der Medizin 20011213

• [In liver cirrhosis, not every 'ammonia lowering drug' improves neuropsychiatric deficit].

  MMW Fortschritte der Medizin 20010301